A Pan-Cancer Analysis of CD161, a Potential New Immune Checkpoint

BACKGROUND: CD161, encoded by killer cell lectin-like receptor B1 gene, is a newly reported candidate inhibitor of tumour-infiltrating T cells. Antibody-mediated CD161 blockade enhances T cell-mediated killing of cancer cells in vitro and in vivo in several tumour types. We evaluated the role of CD1...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Immunol
Egile Nagusiak: Zhou, Xiaohan, Du, Jun, Liu, Chengdong, Zeng, Hanyi, Chen, Yuting, Liu, Li, Wu, Dehua
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2021
Gaiak:
Immunology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8299557/
https://ncbi.nlm.nih.gov/pubmed/34305920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.688215
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak